131 related articles for article (PubMed ID: 3628336)
1. Clinical relevance of theophylline chronokinetics for asthmatic children.
Smolensky MH; Scott PH; McGovern JP
Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of day-night differences in serum theophylline concentration with special reference to Theo-Dur.
Smolensky MH; Scott PH; Kramer WG
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):716-22. PubMed ID: 3771961
[TBL] [Abstract][Full Text] [Related]
3. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
4. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
[TBL] [Abstract][Full Text] [Related]
5. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
Tal A; Aviram M; Gorodischer R
J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
7. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
Rogers RJ; Wiener MB; Hill MR; Szefler SJ
Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
[TBL] [Abstract][Full Text] [Related]
8. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
10. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma.
Reinberg A; Pauchet F; Ruff F; Gervais A; Smolensky MH; Levi F; Gervais P; Chaouat D; Abella ML; Zidani R
Chronobiol Int; 1987; 4(3):409-19. PubMed ID: 3315270
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
12. Administration-time-dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children.
Smolensky MH; Scott PH; Harrist RB; Hiatt PH; Wong TK; Baenziger JC; Klank BJ; Marbella A; Meltzer A
Chronobiol Int; 1987; 4(3):435-47. PubMed ID: 3315272
[TBL] [Abstract][Full Text] [Related]
13. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
15. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
[TBL] [Abstract][Full Text] [Related]
17. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic equivalence of a generic slow-release theophylline tablet.
Hendeles L; Breton AL; Beaty R; Harman E
Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942
[TBL] [Abstract][Full Text] [Related]
19. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
Goldenheim PD; Conrad EA; Schein LK
Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
[TBL] [Abstract][Full Text] [Related]
20. [Posture and circadian variations in serum theophylline concentrations].
Kishida M; Hukushima K; Iikura Y
Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
